Meeting
2024 ASCO Annual Meeting
Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples.
Authors
Chaugiang Duong
NeoGenomics Laboratories, Aliso Viejo, CA
Chaugiang Duong , Roisin Puentes , Nathan Montgomery , Derek Lyle , Fernando J. Lopez-Diaz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Quality Care/Health Services Research
Track
Care Delivery and Quality Care
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 11185)
DOI
10.1200/JCO.2024.42.16_suppl.11185
Abstract #
11185
Poster Bd #
380
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
First Author: Lindsay Carol Overton
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Use of tumor-informed ctDNA across gastrointestinal cancers.
First Author: Matthew Reilley
Poster
2022 ASCO Annual Meeting
Investigating the impact of NGS data availability on clinical decision-making in brain cancer.
First Author: Adam Eckburg
Poster
2017 ASCO Quality Care Symposium
Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts.
First Author: Eman Biltaji